The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology, Chongqing Eye Institute, Chongqing Branch (Municipality Division) of National Clinical Research Center for Ocular Diseases, Chongqing, People's Republic of China.
Ocul Immunol Inflamm. 2024 Apr;32(3):326-335. doi: 10.1080/09273948.2023.2170251. Epub 2023 Jan 25.
PURPOSE: To provide an overview on global uveitis research in the last decade in terms of countries/regions, organizations, scholars, journals, trending topics, and fundings. METHODS: This cross-sectional bibliometric analysis yielded 10656 uveitis publications in English for subsequent bibliometric analysis. RESULTS: In terms of the number of publications, the leading country/region was the USA (3007). The most productive organization was the University College London (420). The most productive research team was Professor Yang's group (146). A higher h-index was noted in University College London (48). Professor Rosenbaum was the first h-index holder (32). Keywords of interest included topics such as biologics, COVID and OCT. Publications by (968) ranked the first position. CONCLUSIONS: The USA is the leading force in uveitis study. Asian countries/regions, such as China (mainland) and India, are exerting a substantial role worldwide. Trendy topics cover COVID-19, OCTA.
目的：从国家/地区、组织、学者、期刊、热门主题和资金等方面，对过去十年全球葡萄膜炎研究进行概述。
方法：本横断面文献计量学分析提供了 10656 篇英文葡萄膜炎文献，随后进行了文献计量学分析。
结果：就出版物数量而言，领先的国家/地区是美国（3007 篇）。最具生产力的组织是伦敦大学学院（420 篇）。最具生产力的研究团队是杨教授的团队（146 篇）。伦敦大学学院的 h 指数较高（48）。罗森鲍姆教授是第一个 h 指数持有者（32）。感兴趣的关键词包括生物制剂、COVID 和 OCT 等主题。出版物数量排名第一的是（968）。
结论：美国是葡萄膜炎研究的主导力量。亚洲国家/地区，如中国大陆和印度，在全球范围内发挥着重要作用。热门话题包括 COVID-19、OCTA。
Ocul Immunol Inflamm. 2024-4
Zhonghua Yan Ke Za Zhi. 2024-4-11
Arch Osteoporos. 2020-8-17
Front Biosci (Landmark Ed). 2022-8-31
J Control Release. 2022-5
Front Endocrinol (Lausanne). 2023
Medicine (Baltimore). 2024-9-27
J Neuroinflammation. 2024-5-22
Front Med (Lausanne). 2023-9-20
Int Ophthalmol. 2023-11
Zotero 插件